# Ixabepilone

## Ixempra inj 15mg (2mg/mL)

##### 臨採

| TAH Drug Code      | [IIXE](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IIXE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Breast cancer (metastatic or locally advanced)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | 40 mg/m2 infused intravenously over 3 hours once every 3 weeks. Doses for patients with body surface area (BSA) greater > 2.2 m2 should be calculated based on 2.2 m2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | History of severe (grade 3 or 4) hypersensitivity to polyoxyethylated castor oil (Cremophor EL) or its derivatives; neutrophil count <1,500/mm3 or platelet count <100,000/mm3; combination therapy with ixabepilone and capecitabine in patients with AST or ALT >2.5 times ULN or bilirubin >1 times ULN                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Adverse Effects    | >10%: Peripheral neuropathy (63%; grades 3/4: 14%; grade 3/4 median onset: Cycle 4), peripheral sensory neuropathy (62%; grades 3/4: 14%), headache (11%), Alopecia (48%), Nausea (42%), vomiting (29%), mucositis (?29%), stomatitis (?29%), diarrhea (22%), anorexia (19%), constipation (16%), abdominal pain (13%), Leukopenia (grade 3: 36%; grade 4: 13%), neutropenia (grade 3: 31%; grade 4: 23%), Weakness (56%), arthralgia (?49%), myalgia (?49%), musculoskeletal pain (20%) 1% to 10%: Edema (9%), chest pain (5%), Peripheral motor neuropathy (10%; grade 3: 1%), pain (8%), dizziness (7%), insomnia (5%), Nail disease (9%), skin rash (9%), palmar-plantar erythrodysesthesia (8%), pruritus (6%), desquamation (2%), hyperpigmentation (2%), Hot flash (6%), weight loss (6%), dehydration (2%), Dysgeusia (6%), gastroesophageal reflux (6%), Anemia (grade 3: 6%; grade 4: 2%), febrile neutropenia (3%; grade 3: 3%), thrombocytopenia (grade 3: 5%; grade 4: 2%), Hypersensitivity (5%; grade 3: 1%), Infection (5%), Increased lacrimation (4%), Dyspnea (9%), upper respiratory tract infection (6%), cough (2%), Fever (8%) <1%, postmarketing, and/or case reports: Acute hepatic failure, acute pulmonary edema, angina pectoris, atrial flutter, autonomic neuropathy, blood coagulation disorder, cardiomyopathy, cerebral hemorrhage, colitis, delayed gastric emptying, dysphagia, embolism, enterocolitis, erythema multiforme, gastrointestinal hemorrhage, hemorrhage, hypokalemia, hyponatremia, hypotension, hypovolemia, hypovolemic shock, hypoxia, increased gamma-glutamyl transferase, increased serum alkaline phosphatase, increased serum transaminases, interstitial pneumonitis, intestinal obstruction, jaundice, left ventricular dysfunction, metabolic acidosis, myocardial infarction, nephrolithiasis, neutropenic infection, orthostatic hypotension, pneumonia, pneumonitis, radiation recall phenomenon, renal failure, respiratory failure, sepsis, septic shock, supraventricular cardiac arrhythmia, syncope, thrombosis, trismus, urinary tract infection, vasculitis, voice disorder |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

